Hodgkin's disease in children: adaptation of treatment to risk factors

Recent Results Cancer Res. 1989:117:214-21. doi: 10.1007/978-3-642-83781-4_23.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Adolescent
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Bleomycin / administration & dosage
  • Child
  • Child, Preschool
  • Clinical Trials as Topic
  • Combined Modality Therapy / adverse effects
  • Dacarbazine / administration & dosage
  • Doxorubicin / administration & dosage
  • Female
  • Hodgkin Disease / radiotherapy
  • Hodgkin Disease / therapy*
  • Humans
  • Male
  • Mechlorethamine / administration & dosage
  • Prednisone / administration & dosage
  • Procarbazine / administration & dosage
  • Prognosis
  • Risk Factors
  • Vinblastine
  • Vincristine / administration & dosage

Substances

  • Bleomycin
  • Procarbazine
  • Mechlorethamine
  • Vincristine
  • Vinblastine
  • Dacarbazine
  • Doxorubicin
  • Prednisone

Supplementary concepts

  • ABVD protocol
  • MOPP protocol